MedPath
HSA Approval

RIVASON-20 RIVAROXABAN TABLETS Ph.Eur. 20MG

SIN17168P

RIVASON-20 RIVAROXABAN TABLETS Ph.Eur. 20MG

RIVASON-20 RIVAROXABAN TABLETS Ph.Eur. 20MG

January 17, 2025

ALMA-A PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantALMA-A PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

B01AF01

Manufacturer Information

alma-a pte ltd

Unison Pharmaceuticals Pvt. Ltd.

Active Ingredients

Rivaroxaban

20mg

Rivaroxaban

Documents

Package Inserts

RIVASON Rivaroxaban Tablets 20MG & 15MG PI.pdf

Approved: January 17, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RIVASON-20 RIVAROXABAN TABLETS Ph.Eur. 20MG - HSA Approval | MedPath